← Back
Data updated: Mar 10, 2026
ORIENT PHARMA CO LTD
CardiovascularInfectious DiseaseDermatology
ORIENT PHARMA CO LTD is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Dermatology. Key products include VANCOMYCIN HYDROCHLORIDE.
2014
Since
5
Drugs
-
Trials
35
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
VANCOMYCIN HYDROCHLORIDE 2025-10-02
PITAVASTATIN CALCIUM 2025-06-13
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-05-29
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-03-21
CARISOPRODOL 2024-11-14
Labeling
PITAVASTATIN CALCIUM 2024-11-04
Labeling
EZETIMIBE 2024-10-22
Labeling
EZETIMIBE 2024-10-22
Labeling
PITAVASTATIN CALCIUM 2024-09-27
Labeling
EZETIMIBE 2024-09-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 36%
1 drugs Phase 3: 1
Infectious Disease 21%
1 drugs
Dermatology 21%
1 drugs
Metabolic 21%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
B BRAUN specialty
Infectious Disease, Dermatology, Metabolic, Cardiovascular
Merck big-pharma
Infectious Disease, Cardiovascular, Metabolic
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
Johnson & Johnson big-pharma
Infectious Disease, Cardiovascular, Metabolic
Bayer big-pharma
Cardiovascular, Dermatology, Metabolic
Discontinued (2)
Company Info
- First Approval
- 2014-10-27
- Latest
- 2025-06-13
- Applications
- 5
FDA Sponsor Names
ORIENT PHARMA CO LTDORIENT PHARMA